deltatrials

Stage iv non-small cell lung cancer Trials in Rochester, United States

Conditions / Stage iv non-small cell lung cancer / Rochester, United States

Stage iv non-small cell lung cancer is a medical condition with active clinical research programs worldwide.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID Title Status Phase
NCT00098540 Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer COMPLETED PHASE2
NCT00655655 Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors COMPLETED PHASE1
NCT02206334 Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer COMPLETED PHASE1
NCT02438722 S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer ACTIVE_NOT_RECRUITING PHASE2/PHASE3
NCT00738881 Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer TERMINATED PHASE3
NCT05631574 Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer TERMINATED PHASE1
NCT03137771 Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer ACTIVE_NOT_RECRUITING PHASE2
NCT03087708 Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer TERMINATED PHASE2
NCT00003869 Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer COMPLETED PHASE3
NCT02134912 S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib TERMINATED PHASE2

Related Pages